Amarin to Report First Quarter 2022 Financial Results and Host Conference Call On May 4, 2022
19 April 2022 - 9:30PM
Amarin Corporation plc (NASDAQ:AMRN) today announced that it will
host a conference call with members of Amarin’s senior management
team to discuss the Company's first quarter 2022 financial results
on Wednesday, May 4, 2022 at 8:00 a.m. ET. The conference call will
follow the anticipated release of the Company's financial results
earlier that day.
Conference Call and Webcast
Information:Access to live call:Go to the investor
relations section of the Company's website
at www.amarincorp.comDial in within the United States:
888-506-0062International dial in: 973-528-0011Access Code:
930259
Access to replay:Dial in within the United States:
877-481-4010International dial in: 919-882-2331Access Code:
45008The replay of the call will also be available through the
Company's website shortly after the call and be made available for
a period of two weeks.
About Amarin Amarin is
an innovative pharmaceutical company leading a new paradigm in
cardiovascular disease management. From our scientific research
foundation to our focus on clinical trials, and now our global
commercial expansion, we are evolving and growing rapidly. Amarin
has offices in Bridgewater, New Jersey in the United States,
Dublin, in Ireland, Zug in Switzerland, and other countries in
Europe as well as commercial partners and suppliers around the
world. We are committed to rethinking cardiovascular risk through
the advancement of scientific understanding of the impact on
society of significant residual risk that exists beyond traditional
therapies, such as statins for cholesterol
management.
Amarin Contact Information
Investor Inquiries: Lisa DeFrancesco Investor Relations
Amarin Corporation plc investor.relations@amarincorp.com
(investor inquiries)
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From Apr 2024 to May 2024
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From May 2023 to May 2024